Other News To Note
• AVI BioPharma Inc., of Bothell, Wash., said it changed its name to Sarepta Therapeutics Inc. and its stock ticker to "SRPT." The firm also effected a 1-for-6 reverse stock split. The firm is working on RNA-based therapeutics, including lead drug eteplirsen for Duchenne's muscular dystrophy.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter